When Medical Device Cybersecurity Becomes a Crime | Ep. 36

The Med Device Cyber Podcast · September 30, 2025 In "When Medical Device Cybersecurity Becomes a Crime," episode 36 of The Med Device Cyber Podcast, we explore the significant shift in medical device cybersecurity enforcement. Historically, cybersecurity issues in healthcare primarily fell under HIPAA, focusing on data privacy. However, a recent Department of Justice (DOJ) enforcement action against Illumina highlights a new era: when cybersecurity flaws in medical devices lead to patient harm, they can result in legal prosecution under the False Claims Act.This episode delves into the critical distinction between data breaches and direct patient safety risks inherent in compromised medical devices like infusion pumps or pacemakers. The discussion emphasizes that known, unmitigated cybersecurity risks, especially when misrepresented to federal healthcare organizations, can lead to severe consequences, including misdiagnosis, mistreatment, and even death. The hosts discuss the challenges medical device manufacturers face in integrating cybersecurity by design from the outset, particularly with the FDA's evolving guidance (specifically September 2023) and lengthy development cycles. The conversation underscores the growing recognition of cybersecurity as a clinical risk, moving beyond theoretical concerns to tangible patient mortality. It also touches on the secure product development framework (SPDF) and evolving regulatory strategies, acknowledging a slow but positive shift in industry awareness and proactive engagement with cybersecurity, despite the inherent tensions of speed-to-market pressures. The episode concludes with a look at the future of medical device security, emphasizing the importance of aligning organizational functions to address cybersecurity throughout the total product life cycle.

Key Takeaways

• A recent Department of Justice enforcement against Illumina under the False Claims Act signifies a major shift, making medical device cybersecurity failures a prosecutable offense, not just a penalty.
• Unlike HIPAA, which focuses on health information privacy, current enforcement prioritizes direct patient safety concerns arising from compromised medical devices, where cyberattacks can lead to tangible physical harm or death.
• The medical device industry is challenged by the FDA's relatively new cybersecurity guidance (September 2023) and lengthy development cycles, which often necessitate retrofitting security into products already in development.
• Companies are increasingly adopting proactive regulatory strategies, including anticipating FDA deficiencies and preparing remediation plans during review cycles, to expedite market entry and enhance cybersecurity.
• The industry is slowly recognizing cybersecurity as an acute clinical risk, with a growing understanding that poor security can directly contribute to patient mortality through delayed treatment or device malfunction, necessitating a "security by design" approach from the start of the total product life cycle.
• Adherence to a secure product development framework (SPDF) from the early stages of development is becoming crucial for medical device manufacturers to mitigate legal, regulatory, and patient safety risks.
• Manufacturers must align sales, engineering, marketing, and compliance teams to ensure device security from initial development throughout the total product life cycle, especially given the high failure rate of MedTech startups that overlook regulatory complexities.
• Misrepresenting cybersecurity protections, particularly to federally funded healthcare organizations, can invoke severe legal repercussions, highlighting the increased government oversight and scrutiny.
• The transition from cybersecurity as a technical risk to a significant legal and clinical risk is fundamentally reshaping how medical device manufacturers approach product security and regulatory compliance.
• The proactive integration of security controls and documentation throughout the entire development process reduces the likelihood of costly and time-consuming remediations later on, especially as regulatory bodies intensify their cybersecurity focus.

Listen on mdcpodcast.com · Watch on YouTube

Listen to this episode

• Watch on YouTube
• Listen on Apple Podcasts
• Listen on Spotify
• Browse all episodes

---

Want help applying this to your own device program?

Blue Goat Cyber is a specialist medical device cybersecurity firm: 250+ FDA submissions, zero rejections. If anything in this conversation hit close to home, book a 30-minute strategy session - no cost, no obligation.